IE851368L - Preparing hmg-coa reductase inhibitors - Google Patents

Preparing hmg-coa reductase inhibitors

Info

Publication number
IE851368L
IE851368L IE136885A IE136885A IE851368L IE 851368 L IE851368 L IE 851368L IE 136885 A IE136885 A IE 136885A IE 136885 A IE136885 A IE 136885A IE 851368 L IE851368 L IE 851368L
Authority
IE
Ireland
Prior art keywords
coa reductase
reductase inhibitors
preparing hmg
hmg
preparing
Prior art date
Application number
IE136885A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to IE136885A priority Critical patent/IE851368L/en
Publication of IE851368L publication Critical patent/IE851368L/en

Links

IE136885A 1985-05-31 1985-05-31 Preparing hmg-coa reductase inhibitors IE851368L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE136885A IE851368L (en) 1985-05-31 1985-05-31 Preparing hmg-coa reductase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE136885A IE851368L (en) 1985-05-31 1985-05-31 Preparing hmg-coa reductase inhibitors

Publications (1)

Publication Number Publication Date
IE851368L true IE851368L (en) 1985-12-04

Family

ID=11026163

Family Applications (1)

Application Number Title Priority Date Filing Date
IE136885A IE851368L (en) 1985-05-31 1985-05-31 Preparing hmg-coa reductase inhibitors

Country Status (1)

Country Link
IE (1) IE851368L (en)

Similar Documents

Publication Publication Date Title
GR862006B (en) Novel hmg-coa reductase inhibitors
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
PH25350A (en) PHOSPHOROUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS
JPS6426535A (en) Novel hmg-coa reductase inhibitor
AU5288186A (en) Novel peptidase inhibitors
AU3313589A (en) 17beta-n-monosubstituted carbamoyl or 17beta-acyl-4-aza- 5alpha-androst-1-en-3-ones as 5alpha reductase inhibitors
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
PH27278A (en) Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors
GB2205838B (en) Phosphorus-containing hmg-coa reductase inhibitors
ZA886468B (en) Novel hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
DE3573780D1 (en) A process for the preparation of hmg-coa reductase inhibitors and intermediate compounds employed therein
GR862032B (en) Dopamine-b-hydroxylase inhibitors
ZW21586A1 (en) Dopamine-b-hydroxylase inhibitors
EP0415488A3 (en) 7-substituted hmg-coa reductase inhibitors
EP0306263A3 (en) Novel hmg-coa reductase inhibitors
ZA874487B (en) Novel hmg-coa reductase inhibitors
GB8520366D0 (en) Liners
IE861739L (en) Hmg-coa reductase inhibitors
EP0468974A4 (en) Novel hmg-coa reductase inhibitors
GR860362B (en) Dopamine -b-hydroxylase inhibitors
IE871654L (en) Novel hmg-coa reductase inhibitors
ZA863425B (en) 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
IE882652L (en) NOVEL HMG-CoA REDUCTASE INHIBITORS
IE822652L (en) HMG-CoA REDUCTASE INHIBITORS